7 results match your criteria: "Tsuchiya Children's Hospital[Affiliation]"
Therapeutic Effectiveness of a Novel Cranial Remolding Helmet (baby band2) for Positional Plagiocephaly: A Multicenter Clinical Observational Study.
J Clin Med
October 2024
Department of Pediatrics and Child Health, Nihon University School of Medicine, Itabashi 173-8610, Japan.
This multicenter study evaluated the efficacy and safety of a novel cranial remolding helmet (baby band2), which is completely custom-made based on the shape of an infant's cranium. The study included 224 full-term infants from moderate to very severe positional plagiocephaly in Japan. Cranial geometry was assessed before and after helmet therapy using a three-dimensional scanner, and changes in the cranial vault asymmetry index (CVAI) were analyzed.
View Article and Find Full Text PDFAutism spectrum disorder with iodine deficiency hypothyroidism in a 6-year-old boy.
Pediatr Int
October 2024
Department of Pediatrics and Child Health, Nihon University School of Medicine, Itabashi ku, Tokyo, Japan.
Clinical features and treatment strategies of febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: a multicenter retrospective observational study in Japan.
Int J Infect Dis
December 2022
Department of Pediatrics, National Hospital Organization Saitama Hospital, Saitama, Japan.
Objectives: The incidence of infections caused by extended-spectrum beta-lactamase (ESBL)-producing bacteria has increased. This study aimed to clarify the risk factors and treatment strategies for febrile urinary tract infection (fUTI) caused by ESBL-producing bacteria in Japanese children.
Methods: A retrospective observational study was conducted in 21 hospitals among children aged <16 years diagnosed with an fUTI between 2008 and 2017.
Clinical characteristics of pediatric febrile urinary tract infection in Japan.
Int J Infect Dis
March 2021
Department of Pediatrics, National Hospital Organization Saitama Hospital, 2-1 Suwa, Wako-shi, Saitama 351-0102, Japan.
Article Synopsis
- - A study in Japan analyzed the clinical features of febrile urinary tract infections (fUTI) in children under 15, examining data from 2,049 cases between 2008 and 2017, primarily focusing on age and gender distribution.
- - The findings revealed a strong male predominance, especially in infants, with 87% of male cases and 53.2% of female cases under 1 year old; the median age of patients was 5 months.
- - The most common bacteria responsible for fUTI were Escherichia coli (76.6%) and Enterococcus spp. (9.8%), prompting the recommendation for Gram staining of urine samples prior to starting antibiotic treatment.
Efficacy of a leukotriene receptor antagonist for pediatric cedar pollen allergy complicated by asthma.
Exp Ther Med
October 2017
Department of Pediatrics, Dokkyo Medical University, Mibu, Tochigi 321-0293, Japan.
Leukotriene receptor antagonists (LTRAs) are identified as a monotherapy for asthma and allergic rhinitis; however, their use in children for treatment of these diseases has not been examined. Accordingly, the present study investigated the efficacy of pranlukast dry syrup for children with both pollinosis and asthma. The subjects were children receiving treatment for asthma who were also diagnosed with cedar pollen allergy.
View Article and Find Full Text PDFProphylactic effectiveness of suplatast tosilate in children with asthma symptoms in the autumn: a pilot study.
Allergol Int
June 2014
Department of Pediatrics, Dokkyo Medical University, Tochigi, Japan.
Background: Exacerbations of bronchial asthma usually occur in the autumn. To our knowledge, however, the effectiveness of drugs for preventing exacerbations of asthma in the autumn has not been studied previously, except for leukotriene receptor antagonists and Omalizmab.
Methods: This study compared the prophylactic effectiveness of suplatast tosilate with that of mequitazine in children with asthma symptoms, which is usually exacerbated in the autumn.
Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
Pediatr Blood Cancer
July 2014
Tsuchiya Children's Hospital, Kuki, Saitama, Japan; HLH/LCH Committees in the Japanese Society of Pediatric Hematology, Tokyo, Japan.
Background: Despite several advances in the treatment of Epstein-Barr virus (EBV) in recent years, patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) do not always show satisfactory outcomes. We here conducted a nationwide survey in Japan to identify prognostic factors of EBV-HLH in children with this disease in an effort to improve the management and the outcomes of these patients.
Procedure: Between January 2003 and June 2008, we enrolled 98 children younger than 18 years of age who were diagnosed with EBV-HLH.